Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Myeloid, Acute | 5 | 2024 | 3524 | 1.230 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2023 | 5445 | 0.990 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2022 | 136 | 0.750 |
Why?
|
DNA, Mitochondrial | 1 | 2023 | 815 | 0.610 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2021 | 651 | 0.600 |
Why?
|
Adoptive Transfer | 1 | 2020 | 844 | 0.600 |
Why?
|
Myelodysplastic Syndromes | 2 | 2023 | 1352 | 0.550 |
Why?
|
Anemia, Aplastic | 1 | 2018 | 226 | 0.540 |
Why?
|
T-Lymphocytes | 5 | 2022 | 10179 | 0.480 |
Why?
|
DNA Modification Methylases | 1 | 2015 | 206 | 0.480 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2023 | 1596 | 0.470 |
Why?
|
Single-Cell Analysis | 2 | 2022 | 2177 | 0.470 |
Why?
|
Leukemia | 1 | 2022 | 1509 | 0.450 |
Why?
|
F-Box Proteins | 1 | 2015 | 196 | 0.450 |
Why?
|
Antigens, Neoplasm | 1 | 2020 | 1988 | 0.410 |
Why?
|
Bone Marrow | 3 | 2022 | 2951 | 0.400 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2024 | 3591 | 0.390 |
Why?
|
Flow Cytometry | 2 | 2019 | 5973 | 0.380 |
Why?
|
Diagnostic Errors | 1 | 2018 | 1256 | 0.380 |
Why?
|
Hematologic Neoplasms | 2 | 2020 | 1832 | 0.370 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3706 | 0.330 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4477 | 0.320 |
Why?
|
Neuroblastoma | 1 | 2015 | 1226 | 0.290 |
Why?
|
Clone Cells | 2 | 2021 | 1692 | 0.280 |
Why?
|
Enzyme Inhibitors | 1 | 2015 | 3794 | 0.230 |
Why?
|
Cell Separation | 2 | 2019 | 1750 | 0.220 |
Why?
|
Recurrence | 3 | 2023 | 8337 | 0.200 |
Why?
|
DNA Methylation | 1 | 2015 | 4286 | 0.190 |
Why?
|
Chromatin | 2 | 2023 | 2931 | 0.190 |
Why?
|
Cell Tracking | 1 | 2022 | 144 | 0.190 |
Why?
|
Allergy and Immunology | 1 | 2019 | 169 | 0.160 |
Why?
|
Leukemia, Myeloid | 1 | 2021 | 707 | 0.150 |
Why?
|
Immunophenotyping | 1 | 2022 | 1880 | 0.140 |
Why?
|
Herpesvirus 4, Human | 1 | 2022 | 1041 | 0.140 |
Why?
|
Phenotype | 4 | 2024 | 16361 | 0.140 |
Why?
|
Receptors, Immunologic | 1 | 2022 | 1423 | 0.140 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 570 | 0.140 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2023 | 1381 | 0.130 |
Why?
|
Transplantation, Homologous | 2 | 2021 | 4777 | 0.130 |
Why?
|
Cell Lineage | 2 | 2022 | 2506 | 0.130 |
Why?
|
Phthalimides | 1 | 2015 | 25 | 0.130 |
Why?
|
Neoadjuvant Therapy | 2 | 2023 | 2727 | 0.130 |
Why?
|
Naphthoquinones | 1 | 2015 | 77 | 0.120 |
Why?
|
Aminoquinolines | 1 | 2015 | 109 | 0.120 |
Why?
|
Leukocytes, Mononuclear | 1 | 2021 | 1836 | 0.120 |
Why?
|
Immunoglobulins | 1 | 2017 | 881 | 0.120 |
Why?
|
Neoplasms | 1 | 2023 | 21675 | 0.120 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 1937 | 0.110 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2023 | 1377 | 0.110 |
Why?
|
Humans | 19 | 2024 | 743811 | 0.110 |
Why?
|
Tryptophan | 1 | 2015 | 478 | 0.110 |
Why?
|
Multiple Myeloma | 2 | 2022 | 5185 | 0.100 |
Why?
|
Immunity, Cellular | 1 | 2018 | 1608 | 0.100 |
Why?
|
Cell Proliferation | 2 | 2018 | 10477 | 0.090 |
Why?
|
Drug Synergism | 1 | 2015 | 1794 | 0.090 |
Why?
|
Mitochondria | 1 | 2023 | 3513 | 0.090 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2022 | 4386 | 0.090 |
Why?
|
Head and Neck Neoplasms | 1 | 2023 | 2736 | 0.090 |
Why?
|
Genotype | 1 | 2024 | 12944 | 0.080 |
Why?
|
Salvage Therapy | 1 | 2015 | 1275 | 0.080 |
Why?
|
B-Lymphocytes | 2 | 2023 | 4665 | 0.080 |
Why?
|
Doxorubicin | 1 | 2015 | 2234 | 0.080 |
Why?
|
Mutation | 2 | 2023 | 29777 | 0.080 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9440 | 0.080 |
Why?
|
Adrenal Cortex Hormones | 1 | 2015 | 1854 | 0.070 |
Why?
|
Pyrimidines | 2 | 2015 | 2945 | 0.070 |
Why?
|
HEK293 Cells | 1 | 2015 | 4204 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4839 | 0.070 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3504 | 0.070 |
Why?
|
Pyrazoles | 1 | 2015 | 1970 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2727 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2022 | 2540 | 0.060 |
Why?
|
Graft vs Host Disease | 1 | 2015 | 2958 | 0.050 |
Why?
|
Animals | 4 | 2023 | 168660 | 0.050 |
Why?
|
Receptors, Complement 3d | 1 | 2022 | 118 | 0.050 |
Why?
|
HLA-A Antigens | 1 | 2022 | 232 | 0.050 |
Why?
|
Azacitidine | 1 | 2023 | 347 | 0.050 |
Why?
|
Mice | 3 | 2023 | 81154 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2015 | 5170 | 0.050 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13691 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11524 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 805 | 0.040 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 16674 | 0.040 |
Why?
|
Epitopes | 1 | 2022 | 2570 | 0.030 |
Why?
|
Paclitaxel | 1 | 2022 | 1705 | 0.030 |
Why?
|
Janus Kinases | 1 | 2015 | 244 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2022 | 3480 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2023 | 2938 | 0.030 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3583 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 2954 | 0.020 |
Why?
|
Nitriles | 1 | 2015 | 953 | 0.020 |
Why?
|
Female | 4 | 2022 | 380020 | 0.020 |
Why?
|
Male | 3 | 2021 | 349776 | 0.020 |
Why?
|
Survival Rate | 1 | 2015 | 12786 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11036 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18027 | 0.010 |
Why?
|
Prognosis | 1 | 2015 | 29052 | 0.010 |
Why?
|
Aged | 2 | 2017 | 163178 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39001 | 0.010 |
Why?
|
Middle Aged | 2 | 2017 | 213241 | 0.010 |
Why?
|
Young Adult | 1 | 2015 | 56392 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2015 | 77410 | 0.000 |
Why?
|
Adult | 1 | 2015 | 213889 | 0.000 |
Why?
|
Concepts
(103)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(47)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_